Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 40%Low 3 · 60%Moderate 0 · 0%High 0 · 0%

Clinical pregnancy · women undergoing assisted reproduction

Coasting showed no clear difference in clinical Pregnancy compared with gonadotrophin‐releasing hormone antagonist (low certainty).

1 finding from 1 review

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
OR 0.74 [0.42, 1.31]
1 study · 190 participants
Low

Clinical pregnancy · women undergoing assisted reproduction

Coasting showed no clear difference in clinical Pregnancy compared with follicle stimulating hormone administration at time of hCG (low certainty).

1 finding from 1 review

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
OR 0.92 [0.43, 2.01]
1 study · 102 participants
Low

Clinical pregnancy · women undergoing assisted reproduction

Coasting showed no clear difference in clinical pregnancy compared with no coasting (low certainty).

1 finding from 1 review

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
OR 0.82 [0.46, 1.44]
2 studies · 207 participants
Low

Clinical pregnancy · women undergoing assisted reproduction

It is very uncertain whether coasting changes clinical Pregnancy compared with early unilateral follicular aspiration (very low certainty).

1 finding from 1 review

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
OR 0.67 [0.25, 1.79]
2 studies · 83 participants
Very low

Clinical pregnancy rate · women undergoing assisted reproduction

It is very uncertain whether coasting changes clinical pregnancy rate compared with cabergoline (very low certainty).

1 finding from 1 review

Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome 2017 · Cochrane Headline outcomes only
OR 0.38 [0.16, 0.88]
2 studies · 120 participants
Very low